Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Management of Severely Elevated Systolic Blood Pressure

Initial Treatment and Monitoring

  • Target a gradual reduction in blood pressure, aiming for no more than 25% reduction in the first hour for patients without compelling conditions, as recommended by the American Heart Association 1

Considerations for Special Populations

  • Clonidine should be used with caution in patients with heart failure as it may potentially worsen symptoms, according to the American College of Cardiology 2

Alternative Therapies

  • For hypertensive emergencies requiring immediate blood pressure reduction, intravenous medications like labetalol, nicardipine, or nitroprusside are preferred over oral clonidine, as suggested by the European Society of Cardiology 3
  • For malignant hypertension, first-line treatments include labetalol, nitroprusside, nicardipine, or urapidil, as recommended by the European Society of Cardiology 3

Long-term Management

  • For long-term management, consider transitioning to first-line antihypertensive agents such as ACE inhibitors, ARBs, dihydropyridine CCBs, or thiazide/thiazide-like diuretics, as recommended by the European Society of Cardiology 4, 5

Avoiding Common Pitfalls

  • Avoid excessive rapid reduction in blood pressure, which can lead to organ hypoperfusion and ischemic events, as warned by the American Heart Association 1